| 发明名称 |
1-Heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 摘要 |
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
|
| 申请公布号 |
US2004023970(A1) |
申请公布日期 |
2004.02.05 |
| 申请号 |
US20030621432 |
申请日期 |
2003.07.17 |
| 申请人 |
WYETH |
发明人 |
BERNOTAS RONALD CHARLES;LENICEK STEVEN EDWARD;ELOKDAH HASSAN MAHMOUD;LI DAVID ZENAN |
| 分类号 |
C07D471/04;A61K31/437;A61K31/454;A61K31/4545;A61K31/4745;A61K31/498;A61K31/503;A61P17/02;A61P25/00;A61P25/22;A61P25/28;A61P25/32;A61P25/34;A61P43/00;C07D487/04;C07D487/08;C07D519/00;(IPC1-7):A61K31/519;A61K31/474;C07D471/02;C07D487/02 |
主分类号 |
C07D471/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
